menu
    • menu

    Company profile for Cure Genetics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cure Genetics is a biotechnology company established by pioneers in CRISPR technologies in 2016 and based in Suzhou, China. We are committed to developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics, which contribute to the next-generation treatment to cancers and genetic diseases. Cure Genetics aims to become a platform of genetic engineering and build proprietary technologic...
    Cure Genetics is a biotechnology company established by pioneers in CRISPR technologies in 2016 and based in Suzhou, China. We are committed to developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics, which contribute to the next-generation treatment to cancers and genetic diseases. Cure Genetics aims to become a platform of genetic engineering and build proprietary technological platform. We have talented scientists from world leading universities, experienced drug development team and high-profile SAB with profound experience in industry, science and clinical practice.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cure GeneticsChina Flag
    Country
    Country
    China
    Address
    Address
    2nd floor, building 20, biomedical industrial park phase ii, no.218, sangtian ...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.curegenetics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cure Car-Nkt Cgg729 Rcc Data: Asgct 2024 Safety Efficacy Presented
    Cure Car-Nkt Cgg729 Rcc Data: Asgct 2024 Safety Efficacy Presented

    23 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cure-genetics-announced-promising-safety-and-efficacy-data-of-car-nkt-product-cgc729-for-rcc-at-asgct-2024-302153612.html

    PR NEWSWIRE
    23 May 2024
    Share Share
    Cure Genetics and Frametact ink $60 M deal to develop gene therapy
    Cure Genetics and Frametact ink $60 M deal to develop gene therapy

    15 Sep 2023

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/26/23025/chinese-startups-cure-genetics-and-frametact-ink-60-m-deal-to-develop-gene-therapy-for-familial-neurological-diseases.html

    BIOSPECTRUM ASIA
    15 Sep 2023
    Share Share
    Cure Genetics and Frametact Reach a $60 Million Collaboration
    Cure Genetics and Frametact Reach a $60 Million Collaboration

    14 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cure-genetics-and-frametact-reach-a-60-million-collaboration-and-licensing-agreement-for-the-development-of-gene-therapy-for-familial-neurological-diseases-301928075.html

    PR NEWSWIRE
    14 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search